NR3C2 and heart failure: Current heart failure guidelines [9,10] provide a number of Class I recommendations for medications in the management of heart failure with reduced ejection fraction, including renin–angiotensin receptor blockers or angiotensin receptor neprilysin inhibitors, beta blockers, aldosterone receptor antagonists, and loop diuretics for patients with evidence of fluid retention (Central Figure).